Phase 2 trials are designed primarily to assess dose-ranging, safety signals, and preliminary efficacy they are not powered to detect rare adverse events or confirm long-term cardiovascular outcomes
If the problem continues, or if you also have symptoms like swelling, pain, fever, or fatigue, call your healthcare provider
Heres a step-by-step guide to our process: Consultation Schedule a consultation with our experienced healthcare professionals, who will assess your medical history, discuss your concerns, and determine if BPC-157 therapy is the right fit for your needs
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis KEY MARKET PLAYERS Pfizer Inc
Polyphenols in Human Health and Disease , 793-818